ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2396

PI3Kdelta Regulates Invadosome Formation and Invasiveness Of Fibroblast-Like Synoviocyte In Rheumatoid Arthritis

Beatrix Bartok1 and G. S. Firestein2, 1Rheumatology, UCSD School of Medicine, La Jolla, CA, 2Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Cell Migration, signal transduction and synovial cells, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Human Etiology and Pathogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fibroblast-like synoviocytes (FLS) in the intimal lining are major effectors of cartilage damage in rheumatoid arthritis (RA). PI3Kdelta, a member of the Class IA phosphoinositide 3-kinases (PI3K), was recently identified as a regulator of aggressive behavior by RA FLS. Invasive migration requires dynamic interactions between the extracellular matrix (ECM), the actin cytoskeleton and the capacity for matrix degradation. The specialized ECM-degrading membrane protrusions like invadopodia in cancer cells or podosomes in macrophages are known to facilitate invasive migration. Therefore, we investigated the role of PI3Kdelta in formation of invadosomes and matrix degradation.

Methods:

To visualize invadosomes, RA FLS were cultured in fluorescent  labeled gelatin coated dishes for 16 h. Invadosomes were identified with anti-cortactin, anti-TKS5, anti-MT1-MMP and phalloidin staining and observed with confocal microscopy.  To quantify the gelatin degradation, we measured the degradation area and normalized it to total cell surface area using Image J software. Co-localization analysis was performed for PI3Kdelta and Akt  with cortactin, TKS5, MT1-MMP or F-actin. MMP expression was analyzed with qPCR following TNF stimulation for 24 h in the presence or absence PI3Kdelta inhibitors (INK007, CAL101) or a PI3Kdelta/gamma inhibitor (IPI145).

Results:

The collective term invadosomes includes podosomes that form in monocytic cells and invadopodia that are associated with cancer cells. First, we examined whether RA synoviocytes spontaneously form extracellular matrix degrading invadosomes. 25-40% of the cells spontaneously formed invadosomes, which was increased by 2.5 fold in presence of TNF or IL-1 (n=5, p<0.04). Because TNF regulates expression and activity of PI3Kdelta in FLS, we next examined cellular distribution of p110delta using confocal microscopy. Immunofluorescence staining revealed colocalization of p110delta with invadopodia markers cortactin, TKS5 and MT1-MMP in TNF treated and control cells. To determine whether PI3Kdelta activity is required for invadosome formation and matrix degradation, cells were plated onto fluorescent gelatin coated dishes in the presence or absence of PI3Kdelta inhibitors INK007, CAL101, IPI145 (0.1-3 uM) or vehicle control. PI3Kdelta inhibition significantly decreased gelatin degradation in a concentration dependent manner, with 65±6% inhibition at 1 uM for INK007 (p< 0.035; similar results for other inhibitors). Furthermore, the percentage of cells with invadosomes was reduced by PI3Kdelta inhibition. Consistent with these findings, phosphorylation and accumulation of Akt, a downstream target of PI3Kdelta, was decreased by PI3Kdelta inhibition at the invadopodia-mediated gelatin degradation site. PI3Kdelta inhibition had no effect on MMP1, 2, 3 and MT1-MMP gene expression in TNF-treated RA FLS.

Conclusion:

PI3Kdelta plays a critical role in invasive matrix degradation by RA FLS by regulating spontaneous and TNF-induced invadosome formation. These observations, together with previous findings that PI3Kdelta regulates FLS migration, growth and survival, suggest that PI3Kdelta inhibition could protect cartilage in RA.


Disclosure:

B. Bartok,
None;

G. S. Firestein,

Infinity Pharmaceuticals,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pi3kdelta-regulates-invadosome-formation-and-invasiveness-of-fibroblast-like-synoviocyte-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology